Shimei Pharmaceutical sprints to the Shenzhen Stock Exchange: Annual revenue of 180 million yuan plans to raise 600 million yuan Jianghong controls 71% of the equity
NoSuchKey
Guess you like
Origin blog.csdn.net/leijianping_ce/article/details/131863031
Recommended
Ranking